Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. ANAB.NASDAQ

AnaptysBio Inc (ANAB NASDAQ) stock market data APIs

$37.71 0.65(1.8%) as of July 26, 2024
Price chart is built with Anychart

AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics. Its products include Rosnilimab, an IgG1 antibody that targets PD-1+ T cells, resulting in their agonism or depletion, broadly impacting pathogenic drivers of autoimmune and inflammatory diseases; and ANB032, a non-depleting antibody that binds to the BTLA checkpoint receptor and inhibits activated T cell proliferation; ANB033, a novel anti-CD122 antagonist antibody that targets the shared common beta subunit of the receptors for IL-15 and IL-2; ANB101, a BDCA2 modulator antibody that specifically targets plasmacytoid dendritic cells (pDCs); and Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 development for the treatment of generalized pustular psoriasis. The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.

AnaptysBio Inc Financial Data Overview

37.06
37.71
-
38.85
36.89
13.36-38.85
1 030 M
27 319 K
22 962 K
-1.64
-0.24
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ANAB',
Type: 'Common Stock',
Name: 'AnaptysBio Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG0026ZDHR0',
ISIN: NULL,
CUSIP: NULL,
CIK: '1370053',
EmployerIdNumber: '20-3828755',
FiscalYearEnd: 'December',
IPODate: '2017-01-26',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

AnaptysBio Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 22 962 K
  • EBITDA -154 223 008
  • Earnings Per Share -6.14
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get AnaptysBio Inc Earnings via APIs

  • Latest Release 2024-05-09
  • EPS/Forecast -1.57

Get AnaptysBio Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get AnaptysBio Inc latest news via APIs

13 Best Short Squeeze Stocks To Buy Now

In this piece, we will take a look at the 13 best short squeeze stocks to buy now. If you want to skip our primer on short squeezing, and some of the greatest short squeezes in history, then you can t...

AnaptysBio Inc CEO Daniel Faga Sells 6,866 Shares

AnaptysBio Inc (NASDAQ:ANAB), a biotechnology company engaged in developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, has reported an insider sale acco...
Do you have any questions?
support@eodhistoricaldata.com